SCHEMBL20433047

SCHEMBL20433047

CC1CN(CCc2ccc(C(=O)NO)cc2)C[C@H](C)N1Cc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 14/20 0.66
▸ HDAC1 Q13547 10/20 0.66
▸ HDAC4 P56524 5/20 0.57
▸ KCNH2 Q12809 1/20 0.57
▸ HDAC8 Q9BY41 4/20 0.52
▸ HDAC11 Q96DB2 3/20 0.50
▸ MELK Q14680 1/20 0.50
▸ HDAC3 O15379 2/20 0.49
▸ HDAC7 Q8WUI4 2/20 0.49
▸ HDAC2 Q92769 2/20 0.49
▸ HDAC10 Q969S8 2/20 0.49
▸ HDAC9 Q9UKV0 2/20 0.49
▸ HDAC5 Q9UQL6 2/20 0.49
▸ KDM1A O60341 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17078992 1.00 HDAC6 (0.66) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL17078469 1.00 HDAC6 (0.66) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL20432651 1.00 HDAC6 (0.66) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL17079034 0.91 HDAC1 (0.66) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL20432824 0.91 HDAC1 (0.66) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL17078938 0.90 HDAC6 (0.79) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL20432701 0.90 HDAC6 (0.79) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL20432756 0.90 HDAC6 (0.79) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL17078727 0.90 HDAC6 (0.79) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL17079049 0.90 HDAC6 (0.79) HDAC6HDAC1HDAC4KCNH2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3116859-B1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2018-08-01 — — EP disclosed
US-9278967-B2 Substituted-quinoxaline-type piperidine compounds and the uses thereof PURDUE PHARMA L.P. (US) 2016-03-08 — — US disclosed
Send feedback